ArticleBMJ open2025

Randomised double-blind placebo-controlled trial protocol to evaluate the therapeutic efficacy of lyophilised faecal microbiota capsules amended with next-generation beneficial bacteria in individuals with metabolic dysfunction-associated steatohepatitis.

Quinten J J Augustijn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.